EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Quick Heal Technologies Limited (QUICKHEAL) fair value: what the stock is really worth

We calculate from audited financials what Quick Heal Technologies Limited is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Technology · IN · ISIN INE306L01010

QH Thin data Sep 13, 2026

Quick Heal Technologies Limited

QUICKHEAL · BSE

Weakest SetupStrongly overvalued and low quality.

!Fair value ₹47.58 · Strongly overvalued (−68%)
!Quality 43/100
!Weak Growth (revenue 5y −4.8 %/yr)
!Loss-making · -4.3% net margin (TTM)
!negative free cash flow
!Narrow moat 17/100
!Evidence only low, so the estimate is less certain

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

₹811.55 ₹125.57 Fair Value ₹47.58 May 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 13, 2026.

How to read this chart

60‑month range ₹125.57 – ₹811.55 · fair‑value band ₹31.40 – ₹59.48 · the ₹147.15 price screens above the ₹47.58 fair value. Dashed = 300-day average. As of Sep 13, 2026.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Quick Heal Technologies Limited engages in the provision of security software products and solutions to consumers, small businesses, government establishments, and corporate houses in India and internationally. The company operates through Consumer, and Enterprise and Government segments.

Show more

Quick Heal Technologies Limited engages in the provision of security software products and solutions to consumers, small businesses, government establishments, and corporate houses in India and internationally. The company operates through Consumer, and Enterprise and Government segments. It offers antivirus solutions, including total security, internet security, antivirus pro, security for mac, total security for android, mobile security, total security multi-device, internet security essential, and total security-festive pack under the Quick Heal brand. The company provides endpoint protection, endpoint protection cloud, EDR, XDR, MDR, ZTNZ, enterprise mobility management, workspace, and data privacy under the Seqrite brand. It sells its products to national distributors, primary dealers, business partners, and website and e-commerce. Quick Heal Technologies Limited was incorporated in 1995 and is based in Pune, India.

Stock analysis

Quick Heal Technologies Limited (QUICKHEAL) currently trades at ₹147.15, while our model-based Fair Value estimate is ₹47.58, implying the stock looks roughly 209.3% overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 96/100, which puts the evidence level at low.

Scenario range: ₹31.40 (bear) to ₹59.48 (bull), the price of ₹147.15 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 43/100 (below-average quality), in the Technology sector.

Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.

Quick Heal Technologies Limited reported revenue of ₹2.6B in FY2026 versus ₹3.4B in FY2022, a compound −6.5%/yr. Reported net income was −₹109M in FY2026.

Key figures

Market cap ₹8.0B (≈ $83.8M) · P/S ratio 3.12 · EPS (TTM) ₹−1.89 · Dividend yield 2.1% · Net margin −4.2% · Return on equity −2.5% · Return on assets (EBIT) −0.2% · Operating margin −47.6%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (medium confidence).

What moves the price

The share trades about 60% below its 52-week high and 18% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Technology peers we cover trades at −12% fair-value upside, at −68%, QUICKHEAL screens richer than that median.

Fair Value models

Bear ₹31.40 Fair Value ₹47.58 Bull ₹59.48
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
NCAV (Graham) ₹40.23 ₹53.90 ₹80.45 51
All 1 models by family
Asset-Based
NCAV (Graham) ₹40.23 ₹53.90 ₹80.45 51

Open the full fair value analysis →

Notify me when QUICKHEAL reaches fair value

Put QUICKHEAL on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 43/100

Of which business quality 44 · Market factors (momentum, volatility) 31

Profitability 15
Margins and returns on capital today
Quality Growth 13
Are margins and returns improving?
Cashflow 16
Earnings quality: real cash, not paper profit
Fin. Strength 77
Balance sheet, leverage, solvency risk
Investment 85
Disciplined investing over empire-building
Low Volatility 65
Calm price path (market factor)
Momentum 23
Price trend over the last 3–12 months (market factor)
52W Momentum 5
Distance to the 52-week high (market factor)
Net Issuance 76
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−6.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−2.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−4.8%
Revenue growth 7 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−2.6%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
37.7% (2021) → −16.6% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
not computed

QUICKHEAL screens 209% overvalued. Compare with SAP SE →

Compare Quick Heal Technologies Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Software - Application · 696 stocks

Beats the industry median on 2/8 measures
Overall it trails its industry peers.
Valuation
Quality Score 44 · Below median
Fair Value upside −67% · Bottom 25%
Profitability
Return on assets −5% · Bottom 25%
Net margin (TTM) −4% · Below median
Operating margin (TTM) −48% · Bottom 25%
Growth and dividend
Revenue growth −21% · Bottom 25%
Dividend yield (TTM) 2.1% · Above median

Valuation Multiplesvs Software - Application median · lower = cheaper

P/S (TTM) 0.03× · Cheapest 25%

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Software - Application stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
SAP SE SAP €177.26 €156.00 −12%
Shopify Inc SHOP C$178.41 C$112.02 −37%
Uber Technologies, Inc UBER $71.67 $102.51 +43%
Salesforce, Inc CRM $247.72 $344.41 +39%
ServiceNow, Inc NOW $132.53 $145.78 +10%
Cadence Design Systems, Inc CDNS $289.37 $224.24 −23%
Snowflake Inc SNOW $328.99 $74.65 −77%
Datadog, Inc DDOG $221.21 $32.92 −85%
Adobe Inc ADBE $252.23 $471.62 +87%
Automatic Data Processing, Inc ADP $268.26 $177.51 −34%

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Quick Heal Technologies Limited · Fair Value
₹47.58 −209%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Quick Heal Technologies Limited Fair Value". https://www.fairvalue-calculator.com/stock/QUICKHEAL

Frequently asked questions

Is Quick Heal Technologies Limited (QUICKHEAL) overvalued or undervalued?
As of Sep 13, 2026, our model estimates a fair value of ₹47.58 versus a price of ₹147.15, about −68% upside (overvalued).
What is the fair value of QUICKHEAL?
Our model-based fair value for Quick Heal Technologies Limited is ₹47.58 (as of Sep 13, 2026), built from audited fundamentals. The current price: ₹147.15.
What is the quality score of QUICKHEAL?
Quick Heal Technologies Limited has a Quality Score of 43/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Quick Heal Technologies Limited (QUICKHEAL)?
Our model-based price target is the fair value of ₹47.58 (as of Sep 13, 2026) from 1 valuation models. Cautious scenario ₹31.40, optimistic scenario ₹59.48. It is a calculation from audited fundamentals, not an analyst target.
What is the Quick Heal Technologies Limited stock forecast for 2026?
Our models put fair value at ₹47.58, about −68% upside versus a price of ₹147.15 (overvalued). Cautious scenario ₹31.40, optimistic scenario ₹59.48. The calculation is refreshed regularly with new filings.
What is the revenue of Quick Heal Technologies Limited (QUICKHEAL)?
Quick Heal Technologies Limited reported trailing-twelve-month revenue of about ₹2.5B (latest available figure, as of Sep 13, 2026).
Does Quick Heal Technologies Limited pay a dividend?
Quick Heal Technologies Limited currently shows a dividend yield of about 2.08% relative to its recent price (as of Sep 13, 2026).
What is the intrinsic value of Quick Heal Technologies Limited (QUICKHEAL)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Quick Heal Technologies Limited it is ₹47.58 per share (as of Sep 13, 2026), against a price of ₹147.15. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Quick Heal Technologies Limited stock overvalued or undervalued in 2026?
As of Sep 13, 2026, QUICKHEAL trades above its calculated fair value: price ₹147.15, fair value ₹47.58, a gap of about −68% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of QUICKHEAL?
No. The price is what the market pays today (₹147.15); the fair value is what the company's own numbers justify (₹47.58). For Quick Heal Technologies Limited the two are ₹99.57 per share apart. That gap is exactly why we show both numbers side by side.
How much is Quick Heal Technologies Limited worth?
The market values Quick Heal Technologies Limited at about ₹8.0B (market capitalisation, as of Sep 13, 2026). Per share that is ₹147.15; our models calculate a fair value of ₹47.58 per share.
What do the bullish and bearish scenarios say about QUICKHEAL?
Our models span a range for Quick Heal Technologies Limited: cautious scenario ₹31.40, base ₹47.58, optimistic ₹59.48 per share (as of Sep 13, 2026, price ₹147.15). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Quick Heal Technologies Limited (QUICKHEAL)?
Balance-sheet figures for Quick Heal Technologies Limited (as of Sep 13, 2026): return on equity −2.5%. They feed the Quality Score of 43/100, which measures business quality independently of the share price.
How far is QUICKHEAL from its 52-week high?
Quick Heal Technologies Limited trades at ₹147.15, about 60% below its 52-week high of ₹371.00 and 18% above the low of ₹125.00 (as of Sep 13, 2026). Distance from the high says nothing about value: that is what the fair value of ₹47.58 is for.
Which stocks are comparable to Quick Heal Technologies Limited?
From the same area (Technology) we also value SAP SE, Shopify Inc, Uber Technologies, Inc, Salesforce, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Quick Heal Technologies Limited stock attractive at the current price?
The data as of Sep 13, 2026: price ₹147.15, calculated fair value ₹47.58 (−68%), Quality Score 43/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of QUICKHEAL calculated?
We run Quick Heal Technologies Limited through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹47.58, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.8 % above its aggregate fair value. Quick Heal Technologies Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What should I pay attention to with Quick Heal Technologies Limited right now?
The price sits above even our optimistic bull case (₹59.48). The favourable scenario is already priced in. Weak quality (43/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (₹31.40 to ₹59.48) leaves room in how you read the outcome.

Key figures of Quick Heal Technologies Limited

How large is the market capitalisation of Quick Heal Technologies Limited (QUICKHEAL)?
The market capitalisation of Quick Heal Technologies Limited is ₹8.0B (≈ $83.8M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Quick Heal Technologies Limited (QUICKHEAL)?
The price-to-sales ratio of Quick Heal Technologies Limited is 3.12 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Quick Heal Technologies Limited (QUICKHEAL)?
Earnings per share at Quick Heal Technologies Limited are ₹−1.89. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Quick Heal Technologies Limited (QUICKHEAL)?
The dividend yield of Quick Heal Technologies Limited is 2.1%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Quick Heal Technologies Limited (QUICKHEAL)?
The net margin of Quick Heal Technologies Limited is −4.2% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Quick Heal Technologies Limited (QUICKHEAL)?
The return on equity (ROE) of Quick Heal Technologies Limited is −2.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Quick Heal Technologies Limited (QUICKHEAL)?
On an EBIT basis the return on assets of Quick Heal Technologies Limited is −0.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Quick Heal Technologies Limited (QUICKHEAL)?
The operating margin of Quick Heal Technologies Limited is −47.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Quick Heal Technologies Limited (QUICKHEAL)?
Revenue at Quick Heal Technologies Limited is growing −21.4% versus a year earlier (3y avg −2.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Quick Heal Technologies Limited (QUICKHEAL)?
Earnings per share at Quick Heal Technologies Limited are growing +58.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Quick Heal Technologies Limited (QUICKHEAL) generate?
The free cash flow of Quick Heal Technologies Limited is −₹300K (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed

Continue in the live analysis

Fair value and trend for 35,000+ stocks, watchlist, comparison and the diversification check. You can also try 14 days of Pro there, no card.

Open the live analysis →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.